Literature DB >> 32969280

Proteomic Analysis Reveals Upregulation of ACE2 (Angiotensin-Converting Enzyme 2), the Putative SARS-CoV-2 Receptor in Pressure-but Not Volume-Overloaded Human Hearts.

Johannes Stegbauer1, Milena Kraus2, Sarah Nordmeyer3,4, Marieluise Kirchner5,6, Matthias Ziehm5,6, Henrik Dommisch7, Sebastian Kelle8, Marcus Kelm3,9, Istvan Baczko10, Ulf Landmesser6,11, Carsten Tschöpe11, Christoph Knosalla4,12, Martin Falcke13, Matthieu-P Schapranow2, Vera Regitz-Zagrosek4,14,15, Philipp Mertins4,5,6, Titus Kuehne3,4,9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32969280     DOI： 10.1161/HYPERTENSIONAHA.120.16261

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  3 in total

Review 1.  Hypertension, a Moving Target in COVID-19: Current Views and Perspectives.

Authors:  Carmine Savoia; Massimo Volpe; Reinhold Kreutz
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

2.  Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury.

Authors:  Susan Bengs; Alexia Rossi; Vera Regitz-Zagrosek; Catherine Gebhard; Martina Haberecker; Nidaa Mikail; Alexander Meisel; Ahmed Haider; Muriel Grämer; Angela Portmann; Atanas Todorov; Christof Schönenberger; Caroline E Gebhard; Gabriela M Kuster
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.379

3.  Identification of Differential Expression Genes between Volume and Pressure Overloaded Hearts Based on Bioinformatics Analysis.

Authors:  Yuanfeng Fu; Di Zhao; Yufei Zhou; Jing Lu; Le Kang; Xueli Jiang; Ran Xu; Zhiwen Ding; Yunzeng Zou
Journal:  Genes (Basel)       Date:  2022-07-19       Impact factor: 4.141
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.